Preferences in treating polyomavirus infection in kidney transplant recipients: A discrete choice experiment with patients, caregivers, and clinicians
Transplant Infectious Disease · 2024
DOI: 10.1111/tid.14390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Chanel H Chong und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Kidney Transplantation, Polyomavirus Infections, Caregivers, Transplant Recipients. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
Treatment strategies for BK polyomavirus (BKPyV) infection in kidney transplant recipients are heterogeneous among clinicians. We aimed to identify the treatment preferences of key stakeholders for BKPyV infection and measure the trade‐offs between treatment outcomes.
Methods
Adult kidney transplant recipients, caregivers, and clinicians were eligible to participate in a discrete choice experiment between February 2021 and June 2022. The five treatment‐related attributes were achieving viral clearance and optimal graft function, as well as reducing the risk of graft loss, acute rejection, and complications. Results were analyzed using multinomial logistic models.
Results
In total, 109 participants (57 kidney transplant recipients, 10 caregivers, and 42 health professionals) were included. The most important attribute was the risk of graft loss, followed by side effects and acute rejection. As the risk of graft loss increased, all participants were less inclined to accept an assigned treatment strategy. For instance, if graft loss risk was increased from 1% to 50%, the probability of uptake of a treatment strategy for BKPyV infection was reduced from 87% to 3%.
Conclusion
Graft loss is the predominant concern for patients, caregivers, and health professionals when deciding on the treatment for BKPyV infection, and should be included in intervention trials of BKPyV infection. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, University of Sydney, Sydney, Australia.
- Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, Australia.
- Centre for Transplant and Renal Research, Westmead Hospital, Westmead, Australia.
- The Alfred Hospital, Melbourne, Australia.
- Australia and New Zealand Dialysis and Transplant Registry, South Australian Health and Medical Research Institute, Adelaide, Australia.
- School of Population and Global Health, University of Melbourne, Melbourne, Australia.
ORCID-Profile: Chanel H Chong
Zitieren
APA
Chong, C. H., Wong, G., Au, E. H., Scholes-Robertson, N., Muthuramalingam, S., Roger, S. D., Keung, K., Jaure, A., Teixeira-Pinto, A., & Howell, M. (2024). Preferences in treating polyomavirus infection in kidney transplant recipients: A discrete choice experiment with patients, caregivers, and clinicians. Transplant Infectious Disease. https://doi.org/10.1111/tid.14390
Vancouver
Chong CH, Wong G, Au EH, Scholes-Robertson N, Muthuramalingam S, Roger SD, et al. Preferences in treating polyomavirus infection in kidney transplant recipients: A discrete choice experiment with patients, caregivers, and clinicians. Transplant Infectious Disease. 2024. doi:10.1111/tid.14390
BibTeX
@article{Chong2024,
author = {Chong, Chanel H and Wong, Germaine and Au, Eric H and Scholes-Robertson, Nicole and Muthuramalingam, Shyamsundar and Roger, Simon D and Keung, Karen and Jaure, Allison and Teixeira-Pinto, Armando and Howell, Martin},
title = {Preferences in treating polyomavirus infection in kidney transplant recipients: A discrete choice experiment with patients, caregivers, and clinicians},
journal = {Transplant Infectious Disease},
year = {2024},
doi = {10.1111/tid.14390}
}
EUVIMED